中国的药品市场：策略性机会分析

中国的药品市场：策略性机会分析 是由出版商Pharmalicensing Ltd.在2007年01月所出版的。 这份英文市场调查报告书包含97 pages 价格从美金1200起跳。

简介

目录

Abstract

China has become an attractive destination for R&D as new opportunities have emerged following its WTO (World Trade Organization) accession. Development has accelerated both industrially and scientifically, and today the Chinese pharmaceutical market is worth around $US12 billion.

Factors fuelling the developmental growth and attracting foreign investors to the area include low labor costs, high quality clinical data and an abundance of R&D collaborative opportunities and facilities.

Global biotechnology within China has also undergone significant growth, promising enormous potential for new companies. Biotechnology companies in the country have already grown quicker than pharmaceutical companies.

The report discusses the whole of the Chinese pharmaceutical market, taking readers through the history and current state of the healthcare system to the regulations governing the country and its growing R&D capabilities. Detailing the driving forces behind the pharma market and including a full breakdown of the biopharma opportunities, including the contacts of active Chinese companies, the report is an essential resource to understand and access this lucrative market.

Reasons to purchase this report:

• Identify key partners
• Assess the current market opportunity
• Learn how newly implemented government changes have altered the face of the industry
• Understand the organization and success of clinical trials in China
• Create strategies for profitable market access into China

The Chinese government also plays an instrumental role in the pharmaceutical development of China. The introduction of WTO guidelines and protection for intellectual property rights has caused a shift in the company structures of China, forcing some to close business or enter into new collaborations.

Ideally suited for individuals wishing to introduce their companies into this emerging market or review the opportunities available, this report provides a perfect resource to identify the current pattern of the market and understand the regulations that operate within the country.

Table of Contents

1. Introduction

2. The Chinese healthcare system

• 2.1. A historical perspective
• 2.2. China' s healthcare system: Reforms
  • 2.2.1. The basic trend of the system reform: Commercialization and market orientation
  • 2.2.2. Achievements in health system reform
  • 2.2.3. Defects in the design of the new rural cooperative medical system

3. The Chinese pharmaceutical industry

• 3.1. History
• 3.2. Industry growth
• 3.3. Pharmaceutical trade (exports and imports)
• 3.4. The pharmaceutical distribution structure in China
• 3.5. Traditional Chinese medicine
  • 3.5.1. Modernization of Chinese medicine
  • 3.5.2. Drawbacks of TCM
  • 3.5.3. TCM worldwide

4. Driving forces behind the Chinese pharmaceutical market

• 4.1. Issues and opportunities in the pharmaceutical market
  • 4.1.1. SWOT analysis
• 4.2. Effect of the Chinese macro-environment on the pharmaceutical industry: A PEST analysis
  • 4.2.1. Political
  • 4.2.2. Economic
  • 4.2.3. Sociological
  • 4.2.4. Technological
  • 4.2.5. The urban-rural divide
  • 4.2.6. Steep market growth
  • 4.2.7. First-class biopharmaceutical institutions
  • 4.2.8. Good manufacturing practices
  • 4.2.9. Huge market potential
  • 4.2.10. Strong support from the Government
  • 4.2.11. Expansion into rural areas
  • 4.2.12. Social culture
  • 4.2.13. The trend toward self-medication

5. Health insurance in China

• 5.1. Government insurance
  • 5.1.1. The rural health protection system
  • 5.1.2. The urban health protection system
• 5.2. Commercial medical insurance in China
• 5.3. Health insurance take-up in China

6. Regulatory environment

• 6.1. Chinese pharmaceutical regulations: A historical perspective
• 6.2. Brief developmental history
• 6.3. Drug regulatory structure and functions
  • 6.3.1. Ministry of Public Health
  • 6.3.2. State Economic Trade Commission
• 6.4. State Food and Drug Administration
  • 6.4.1. New regulations on drug importation
• 6.5. Responsibilities of the SFDA
• 6.6. The registration process- medical devices
  • 6.6.1. Document preparation (stage one)
    • 6.6.1.1. SFDA registration form
    • 6.6.1.2. Legal production qualification
    • 6.6.1.3. Business license for the Chinese agent registering the product
    • 6.6.1.4. Marketing approval from the country of origin
    • 6.6.1.5. Product standards
    • 6.6.1.6. Operation or user manual
    • 6.6.1.7. Test report
    • 6.6.1.8. Clinical trial report
    • 6.6.1.9. Quality guarantee letter
    • 6.6.1.10. Agent authorization letter
    • 6.6.1.11. After-sales authorization
    • 6.6.1.12. Self-guarantee declaration
  • 6.6.2. Type testing and clinical trials (stage two)
    • 6.6.2.1. Type testing
    • 6.6.2.2. Clinical trials
  • 6.6.3. Registration submission (stage three)
  • 6.6.4. Issuance of the registration certificate (stage four)
  • 6.6.5. Registration procedure
  • 6.6.6. China Compulsory Certificate
• 6.7. The registration process- pharmaceuticals
• 6.8. A few practical points regarding the management of SFDA registration
  • 6.8.1. Complicated process
  • 6.8.2. Lengthy process
  • 6.8.3. Consultant support
  • 6.8.4. Product packaging compliance

7. Legal reform: IPR

• 7.1. Patent protection
  • 7.1.1. China' s accession into the WTO
  • 7.1.2. Impact of IPR and regulatory changes
  • 7.1.3. Impact on the industry

8. Research and development in China

• 8.1. Domestic R&D

相关商品

制药企业相关市场调查报告书

膀胱癌相关的各种合作趋势:2007-2012年
Bladder Cancer Partnering 2007-2012
价格 : US $ 995
出版日期 : 2012年05月

脑瘤相关的各种合作趋势:2007-2012年
Brain Cancer Partnering 2007-2012
价格 : US $ 995
出版日期 : 2012年05月

乳癌相关的各种合作趋势:2007-2012年
Breast Cancer Partnering 2007-2012
价格 : US $ 1695
出版日期 : 2012年05月

Pharmalicensing Ltd.发行的制药相关市场调查报告书

药品事业发展授权合约（第3版）

The Licensing Agreement in Pharmaceutical Business Development (3rd Edition)

价格 : US $ 995

出版日期 : 2007年07月

新药早期研发阶段及新药开发阶段的企业联盟

Early Stage and Discovery Deals: Strategy, Structure and Payment Terms 2nd Edition

价格 : US $ 2695

出版日期 : 2006年12月

医院、意外及外伤治疗药之夥伴交易与合作趋势

Partneringdesk Deals and alliances in hospital, accident and trauma

价格 : US $ 2495

出版日期 : 2006年04月

Email Alert(Email 通知) - 最新市场调查报告书

GII 将每天定期更新最新市场调查报书信息，选择您有兴趣的市场分类，我们将用Email的方式让您收到最新讯息!